KAYLA SAYER: Open Payments
NPI 1003563669 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 38 payments from 12 companies in 2025. Trend: 2023 $49 · 2024 $98 · 2025 $979
Food & beverage: $947Education: $32
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $237 |
| Novo Nordisk Inc | 7 | $209 |
| Insulet Corporation | 6 | $198 |
| Lilly USA, LLC | 5 | $93 |
| PFIZER INC. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: MINIMED 780G, Omnipod, Rybelsus, MOUNJARO, Ozempic, SOMAVERT, LEQVIO, Skytrofa.
Industry payments across SD — which companies pay providers there.
